Daniel Wilson
Conseiller Juridique Général chez DYNE THERAPEUTICS, INC.
Profil
Daniel Wilson is currently the Senior Vice President & Head-Legal at Dyne Therapeutics, Inc. He previously worked as the Senior Corporate Counsel at Celgene Corp.
from 2012 to 2020.
Prior to that, he was a Counsel-Intellectual Property at Sumitomo Pharma America, Inc. Mr. Wilson obtained his graduate degree from the University of Pennsylvania in 1994.
He also holds an undergraduate degree from Swarthmore College, which he received in 1992.
In addition, he earned a graduate degree from Boston University School of Law in 1998.
Postes actifs de Daniel Wilson
| Sociétés | Poste | Début |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Conseiller Juridique Général | 01/06/2020 |
Anciens postes connus de Daniel Wilson
| Sociétés | Poste | Fin |
|---|---|---|
| CELGENE | Conseiller Juridique Général | 01/01/2020 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - |
Formation de Daniel Wilson
| Swarthmore College | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
| Boston University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
